- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06359678
The Northstar Trial (Northstar)
Assessing the Accuracy of Catheter Localization With NorthStar Software in Real-Time MRI-Guided Cardiac Ablation
The introduction of real-time MRI-guided cardiac ablation therapy, a significant advancement in interventional medicine, necessitates precise catheter tracking for accurate navigation within the complex cardiac anatomy. The introduction of the NorthStar software as an active tracking system holds promise for improving the precision and efficiency of catheter manipulation during these procedures. However, a rigorous evaluation of its accuracy and reliability in a clinical setting is crucial to validate its viability.
The objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during real-time MRI-guided cardiac ablation therapy.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marco Gotte
- Phone Number: 020-44440123
- Email: mjw.gotte@amsterdamumc.nl
Study Contact Backup
- Name: Luuk Hopman
- Phone Number: 020-44441405
- Email: l.hopman@amsterdamumc.nl
Study Locations
-
-
-
Amsterdam, Netherlands
- Recruiting
- Amsterdam UMC
-
Contact:
- Marco Gotte
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients undergoing a real-time MRI-guided flutter ablation procedure at the Amsterdam UMC.
Exclusion Criteria:
- Lack of legal capacity.
- Insufficient proficiency in the Dutch language.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Northstar
This is the study group
|
Throughout the real-time MRI-guided ablation procedure, the operator will assess the precision of the NorthStar 3D navigation software.
Before commencing the actual ablation, the operator will confirm the alignment of the 3D anatomical shell, generated in NorthStar through specific electrical signals.
Post the ablation procedure, a secondary alignment verification will be conducted to detect any potential drift or shift.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of Catheter Localization
Time Frame: during procedure
|
The primary objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during realtime MRI-guided cardiac ablation therapy.
At the start of the procedure, the catheters will be manoeuvred to the predefined areas within the right side of the heart based on the specific electrical signals in that area.
These locations will be virtually marked within the NorthStar software.
The extent to which these markers maintain their spatial coordinates after the ablation procedure, evaluated by obtained electrical signals, will serve as a quantitative measure of the system's accuracy.
|
during procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Influences of breathing pattern
Time Frame: during procedure
|
To investigate the influence of breathing pattern on the accuracy of catheter localization.
The breathing pattern during the procedure will be monitored and any changes will be related to the accuracy of catheter localization
|
during procedure
|
|
Influences of procedure duration
Time Frame: during procedure
|
To investigate the influence of procedure duration on the accuracy of catheter localization.
|
during procedure
|
|
Influences of complications during ablation
Time Frame: during procedure
|
To investigate the influence of complications during ablation on the accuracy of catheter localization.
Complications during the procedure will be registered and categorized.
|
during procedure
|
|
Influences of patient characteristics
Time Frame: during procedure
|
To investigate the influence of patient characteristics on the accuracy of catheter localization.
Standard patient characteristics will be noted such as BMI, cardiac output and heartrate to investigate if these characteristics will influence the catheter localization.
|
during procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL85844.015.23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Flutter, Atrial
-
University of PennsylvaniaWithdrawnTypical Atrial Flutter | Risk Factors With Future Development of Atrial FlutterUnited States
-
Vivek ReddyCompletedAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Institute for Clinical and Experimental MedicineRecruitingFlutter, Atrial | Catheter Ablation | Cavotricuspid Isthmus Dependent Right Atrial FlutterCzech Republic
-
Angelo BivianoCompleted
-
Taipei Veterans General Hospital, TaiwanBiosense Webster, Inc.Enrolling by invitationAtrial Flutter | Atypical Atrial FlutterTaiwan
-
Hangzhou Dinova EP Technology Co., LtdRecruitingAtrial Fibrillation (AF) | Typical Atrial FlutterChina
-
Kaiser PermanenteActive, not recruitingAtrial Fibrillation and FlutterUnited States
-
Charles University, Czech RepublicCompleted
-
Hospital Universitario Central de AsturiasJohnson & JohnsonUnknown
-
University of ManchesterManchester University NHS Foundation TrustWithdrawn
Clinical Trials on NorthStar
-
Northstar NeuroscienceTerminatedDepressive Disorder | DepressionUnited States